Michael DiMatteo currently serves as Vice President of Medical Affairs Ophthalmology at Stealth BioTherapeutics, a position held since December 2021. Previously, Michael held roles including Executive Director of Medical Affairs at Dicerna Pharmaceuticals, Inc. and within Stealth BioTherapeutics, as well as Senior Director of Medical Affairs. Michael's earlier experience includes leadership positions at Mylan and GlaxoSmithKline, where responsibilities spanned product innovation strategy, R&D business development, and various marketing roles. Michael began the professional journey as a Medical Science Liaison at Warner Lambert - Parke-Davis. Academic credentials include a Ph.D. in Pharmacology and Toxicology from West Virginia University School of Medicine and a BS in Pharmacy from Duquesne University.
Sign up to view 1 direct report
Get started